B97.29
|
Other coronavirus as the cause of diseases classified elsewhere
|
D80.0
|
Hereditary hypogammaglobulinemia
|
D80.1
|
Nonfamilial hypogammaglobulinemia
|
D80.2
|
Selective deficiency of immunoglobulin A [IgA]
|
D80.3
|
Selective deficiency of immunoglobulin G [IgG] subclasses
|
D80.4
|
Selective deficiency of immunoglobulin M [IgM]
|
D80.5
|
Immunodeficiency with increased immunoglobulin M [IgM]
|
D80.6
|
Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia
|
D80.7
|
Transient hypogammaglobulinemia of infancy
|
D80.8
|
Other immunodeficiencies with predominantly antibody defects
|
D80.9
|
Immunodeficiency with predominantly antibody defects, unspecified
|
D81.0
|
Severe combined immunodeficiency [SCID] with reticular dysgenesis
|
D81.1
|
Severe combined immunodeficiency [SCID] with low T- and B-cell numbers
|
D81.2
|
Severe combined immunodeficiency [SCID] with low or normal B-cell numbers
|
D81.30
|
Adenosine deaminase deficiency, unspecified
|
D81.31
|
Severe combined immunodeficiency due to adenosine deaminase deficiency
|
D81.32
|
Adenosine deaminase 2 deficiency
|
D81.39
|
Other adenosine deaminase deficiency
|
D81.4
|
Nezelof's syndrome
|
D81.5
|
Purine nucleoside phosphorylase [PNP] deficiency
|
D81.6
|
Major histocompatibility complex class I deficiency
|
D81.7
|
Major histocompatibility complex class II deficiency
|
D81.810
|
Biotinidase deficiency
|
D81.818
|
Other biotin-dependent carboxylase deficiency
|
D81.819
|
Biotin-dependent carboxylase deficiency, unspecified
|
D81.89
|
Other combined immunodeficiencies
|
D81.9
|
Combined immunodeficiency, unspecified
|
D82.0
|
Wiskott-Aldrich syndrome
|
D82.1
|
Di George's syndrome
|
D82.2
|
Immunodeficiency with short-limbed stature
|
D82.3
|
Immunodeficiency following hereditary defective response to Epstein-Barr virus
|
D82.4
|
Hyperimmunoglobulin E [IgE] syndrome
|
D82.8
|
Immunodeficiency associated with other specified major defects
|
D82.9
|
Immunodeficiency associated with major defect, unspecified
|
D83.0
|
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
|
D83.1
|
Common variable immunodeficiency with predominant immunoregulatory T-cell disorders
|
D83.2
|
Common variable immunodeficiency with autoantibodies to B- or T-cells
|
D83.8
|
Other common variable immunodeficiencies
|
D83.9
|
Common variable immunodeficiency, unspecified
|
D84.0
|
Lymphocyte function antigen-1 [LFA-1] defect
|
D84.1
|
Defects in the complement system
|
J06.9
|
Acute upper respiratory infection, unspecified
|
J09.X1
|
Influenza due to identified novel influenza A virus with pneumonia
|
J09.X2
|
Influenza due to identified novel influenza A virus with other respiratory manifestations
|
J09.X3
|
Influenza due to identified novel influenza A virus with gastrointestinal manifestations
|
J09.X9
|
Influenza due to identified novel influenza A virus with other manifestations
|
J12.0
|
Adenoviral pneumonia
|
J12.1
|
Respiratory syncytial virus pneumonia
|
J12.3
|
Human metapneumovirus pneumonia
|
J12.81
|
Pneumonia due to SARS-associated coronavirus
|
J12.82
|
Pneumonia due to coronavirus disease 2019
|
J12.89
|
Other viral pneumonia
|
J12.9
|
Viral pneumonia, unspecified
|
J16.8
|
Pneumonia due to other specified infectious organisms
|
J18.0
|
Bronchopneumonia, unspecified organism
|
J18.1
|
Lobar pneumonia, unspecified organism
|
J18.2
|
Hypostatic pneumonia, unspecified organism
|
J18.8
|
Other pneumonia, unspecified organism
|
J18.9
|
Pneumonia, unspecified organism
|
J20.8
|
Acute bronchitis due to other specified organisms
|
J22
|
Unspecified acute lower respiratory infection
|
R05.1
|
Acute cough
|
R05.2
|
Subacute cough
|
R05.3
|
Chronic cough
|
R05.8
|
Other specified cough
|
R06.2
|
Wheezing
|
R50.9
|
Fever, unspecified
|
T80.82XS
|
Complication of immune effector cellular therapy, sequela
|
Z03.818
|
Encounter for observation for suspected exposure to other biological agents ruled out
|
Z20.822
|
Contact with and (suspected) exposure to COVID-19
|
Z20.828
|
Contact with and (suspected) exposure to other viral communicable diseases
|
Z86.16
|
Personal history of COVID-19
|
Z92.850
|
Personal history of Chimeric Antigen Receptor T-cell therapy
|
Z92.858
|
Personal history of other cellular therapy
|
Z92.86
|
Personal history of gene therapy
|
Z94.0
|
Kidney transplant status
|
Z94.1
|
Heart transplant status
|
Z94.2
|
Lung transplant status
|
Z94.3
|
Heart and lungs transplant status
|
Z94.4
|
Liver transplant status
|
Z94.5
|
Skin transplant status
|
Z94.6
|
Bone transplant status
|
Z94.81
|
Bone marrow transplant status
|
Z94.82
|
Intestine transplant status
|
Z94.83
|
Pancreas transplant status
|
Z94.84
|
Stem cells transplant status
|
U07.1
|
COVID-19
|